In vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis

Int J Cardiovasc Imaging. 2009 Mar;25(3):251-7. doi: 10.1007/s10554-008-9377-2. Epub 2008 Nov 1.

Abstract

We investigated the ability of fluorodeoxyglucose positron emission tomography (FDG PET) imaging to serially monitor macrophage content in a rabbit model of atherosclerosis. Atherosclerosis was induced in rabbits (n = 8) by a combination of atherogenic diet and balloon denudation of the aorta. At the end of nine months, the rabbits were randomized to a further six months of the same atherogenic diet (progression group) or normal diet (regression group). In vivo uptake of FDG by the thoracic aorta was measured using aortic uptake-to-blood radioactivity ratios at the start and end of the randomized period. A significant increase in FDG uptake of the progression group after continued cholesterol feeding (aortic uptake-to-blood radioactivity: 0.57 +/- 0.02 to 0.68 +/- 0.02, P = 0.001), and a corresponding fall in FDG uptake of the regression group after returning to a normal chow diet (aortic uptake-to-blood radioactivity ratios: 0.67 +/- 0.02 to 0.53 +/- 0.02, P < 0.0001). FDG PET can quantify in vivo macrophage content and serially monitor changes in FDG activity in this rabbit model.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Atherosclerosis / diagnostic imaging*
  • Atherosclerosis / pathology
  • Diet, Atherogenic
  • Disease Models, Animal
  • Disease Progression
  • Fluorodeoxyglucose F18 / pharmacokinetics
  • Positron-Emission Tomography / methods*
  • Rabbits
  • Radiographic Image Interpretation, Computer-Assisted
  • Radiopharmaceuticals / pharmacokinetics
  • Random Allocation

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18